Your session is about to expire
← Back to Search
Neuromodulation Device
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)
N/A
Waitlist Available
Research Sponsored by Neurent Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new device called the NEUROMARK System for people with chronic nasal congestion and runny nose. It aims to help those who haven't been helped by usual treatments by targeting the nerves in the nose.
Eligible Conditions
- Hay Fever
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Efficacy
Safety
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental: TreatmentExperimental Treatment1 Intervention
Subjects will undergo treatment with the NEUROMARK System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NEUROMARK System
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Neurent MedicalLead Sponsor
4 Previous Clinical Trials
505 Total Patients Enrolled
Annalise SorensenStudy DirectorNeurent Medical
3 Previous Clinical Trials
373 Total Patients Enrolled